Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,768 | -182,024 | -162,155 | -120,247 | -63,888 |
| Depreciation Amortization | 295 | 2,355 | 2,088 | 1,585 | 875 |
| Accounts receivable | 601 | -16,550 | -6,689 | -4,804 | -5,604 |
| Accounts payable and accrued liabilities | 840 | -578 | 2,744 | 10,001 | 4,423 |
| Other Working Capital | -528 | -10,506 | 18,019 | 24,898 | 8,016 |
| Other Operating Activity | 6,660 | 60,391 | 36,615 | 16,255 | 12,239 |
| Operating Cash Flow | $-24,900 | $-146,912 | $-109,378 | $-72,312 | $-43,939 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,058 | -1,726 | -4,158 | 32,012 | 11,934 |
| PPE Investments | -224 | -1,598 | -1,187 | -1,310 | -988 |
| Investing Cash Flow | $36,834 | $-3,324 | $-5,345 | $30,702 | $10,946 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -208 | 75,059 | -543 | -322 | -637 |
| Other Financing Activity | 0 | 0 | 75,163 | 0 | 0 |
| Financing Cash Flow | $-208 | $75,059 | $74,620 | $-322 | $-637 |
| Beginning Cash Position | 15,364 | 90,541 | 90,541 | 90,541 | 90,541 |
| End Cash Position | 27,090 | 15,364 | 50,438 | 48,609 | 56,911 |
| Net Cash Flow | $11,726 | $-75,177 | $-40,103 | $-41,932 | $-33,630 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,900 | -146,912 | -109,378 | -72,312 | -43,939 |
| Capital Expenditure | -224 | -1,825 | -1,411 | -1,366 | -1,044 |
| Free Cash Flow | -25,124 | -148,737 | -110,789 | -73,678 | -44,983 |